These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6388524)

  • 21. A placebo-controlled, double-blind trial of amitriptyline in bulimia.
    Mitchell JE; Groat R
    J Clin Psychopharmacol; 1984 Aug; 4(4):186-93. PubMed ID: 6381556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
    Robinson DS; Lerfald SC; Bennett B; Laux D; Devereaux E; Kayser A; Corcella J; Albright D
    Psychopharmacol Bull; 1991; 27(1):31-9. PubMed ID: 1862204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
    Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
    Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of panic attacks on response to phenelzine and amitriptyline in depressed outpatients.
    Kayser A; Robinson DS; Yingling K; Howard DB; Corcella J; Laux D
    J Clin Psychopharmacol; 1988 Aug; 8(4):246-53. PubMed ID: 3062042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of phenelzine and haloperidol in borderline personality disorder.
    Soloff PH; Cornelius J; George A; Nathan S; Perel JM; Ulrich RF
    Arch Gen Psychiatry; 1993 May; 50(5):377-85. PubMed ID: 8489326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychopharmacologic validation of atypical depression.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin JG; Tricamo E; Markowitz JS; Klein DF
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):22-5. PubMed ID: 6376483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenelzine vs atenolol in social phobia. A placebo-controlled comparison.
    Liebowitz MR; Schneier F; Campeas R; Hollander E; Hatterer J; Fyer A; Gorman J; Papp L; Davies S; Gully R
    Arch Gen Psychiatry; 1992 Apr; 49(4):290-300. PubMed ID: 1558463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bulimia and monoamine oxidase inhibitors: a predictor study.
    Hardy BW; Waller DA; Orsulak PJ
    Tex Med; 1985 Oct; 81(10):39-42. PubMed ID: 3904070
    [No Abstract]   [Full Text] [Related]  

  • 30. Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.
    Quitkin FM; McGrath PJ; Stewart JW; Harrison W; Wager SG; Nunes E; Rabkin JG; Tricamo E; Markowitz J; Klein DF
    Arch Gen Psychiatry; 1989 Sep; 46(9):787-93. PubMed ID: 2673130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to phenelzine among depressed patients with features of hysteroid dysphoria.
    Kayser A; Robinson DS; Nies A; Howard D
    Am J Psychiatry; 1985 Apr; 142(4):486-8. PubMed ID: 3883817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder.
    Frank JB; Kosten TR; Giller EL; Dan E
    Am J Psychiatry; 1988 Oct; 145(10):1289-91. PubMed ID: 3048121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo.
    Raft D; Davidson J; Wasik J; Mattox A
    Neuropsychobiology; 1981; 7(3):122-6. PubMed ID: 7231652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant drug therapy for bulimia: current status.
    Pope HG; Hudson JI
    J Clin Psychiatry; 1986 Jul; 47(7):339-45. PubMed ID: 3087968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are anorexic and bulimic patients depressed?
    Herzog DB
    Am J Psychiatry; 1984 Dec; 141(12):1594-7. PubMed ID: 6594940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacotherapy of social phobia: an interim report of a placebo-controlled comparison of phenelzine and atenolol.
    Liebowitz MR; Gorman JM; Fyer AJ; Campeas R; Levin AP; Sandberg D; Hollander E; Papp L; Goetz D
    J Clin Psychiatry; 1988 Jul; 49(7):252-7. PubMed ID: 3292516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of bulimic symptoms with methylamphetamine.
    Ong YL; Checkley SA; Russell GF
    Br J Psychiatry; 1983 Sep; 143():288-93. PubMed ID: 6354341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design.
    Quitkin FM; Harrison W; Stewart JW; McGrath PJ; Tricamo E; Ocepek-Welikson K; Rabkin JG; Wager SG; Nunes E; Klein DF
    Arch Gen Psychiatry; 1991 Apr; 48(4):319-23. PubMed ID: 2009033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients.
    Georgotas A; McCue RE; Friedman E; Cooper TB
    J Clin Psychopharmacol; 1987 Dec; 7(6):413-6. PubMed ID: 3323263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An outpatient evaluation of phenelzine and imipramine.
    Davidson J; Raft D; Pelton S
    J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.